Global Animal Biotechnology Market Size, Share, Forecast: Product Type: Reproductive and Genetic Products, Diagnostic Tests, Drugs, Vaccines; By Application: Food Safety and Drug Development, Development of Animal Pharmaceuticals; Regional Analysis; Competitive Landscape; Industry Events and Developments; 2024-2032

Global Animal Biotechnology Market Outlook

The global animal biotechnology market size reached a value of about USD 27.75 billion in 2023. The market is growing at a rapid rate and is likely to register a CAGR of about 7% in the forecast period of 2024-2032. The market is likely to attain a value of 51.01 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

News and Developments in the Market for Animal Biotechnology

In March 2023, following a safety inspection, FDA declared its first low-risk decision for the advertising of products from genome-edited beef cattle and their offspring. This examination is used as a case study in Centre Veterinary Medicine CVM's webinar to show how the agency concluded that the Intentional Genomic Alterations (IGA) did not raise any safety concerns.

Later, FDA’s Centre for Veterinary Medicine released a pre-recorded webinar to inform about the low-risk inspection process and animals that can pose a low risk for genome alterations.  This has added to the growing animal biotechnology market demand.

In October 2021, the members of the House Agriculture Committee had urged both organisations, the United States Department of Agriculture (USDA) and the Food and Drug Administration (FDA) to call for an efficient, modernised, and science-based animal biotechnology regulatory system to implement innovations in the market on time.

The current regulatory system is slow in releasing creations, and so, officials are requesting for the management to be handed over to USDA from FDA’s control.  Such initiatives have been boosting the animal biotechnology market growth.

In October 2021, the Department of Biotechnology launched the ‘One Health’ program. This program aims to detect Zoonotic infections and transboundary diseases all over India. This program was driven by the adverse effects of the COVID-19 pandemic, as it showed that the risk of infectious organisms crossing the species boundary is rising.

In January 2021, a boar semen life extender formula was given a patent. The formula was developed to improve the post-thaw fertility and conception rate to develop cryopreservation facilities for the semen. This will help in increasing productivity, benefiting the pig farmers, animal husbandry departments, and researchers.

Rising Support from the Governments, Increasing Vaccine Development, and Thriving Population to Drive the Animal Biotechnology Market

Animal biotechnology refers to a branch of biotechnology in which with the utilisation of molecular biology techniques, animals are altered genetically. The aim is to produce genetically modified animals with improved growth rates and increased disease resistance. It improves the production and their usefulness for different fields such as agriculture, industrial, and pharmaceutical. This is done using various technologies such as artificial insemination (AI), Embryo Transfer (ET), and In-Vitro Fertilisation (IVF), among others.

• The increasing number of initiatives taken by the government to promote animal healthcare, funding to improve health infrastructure, and collaborations with other governments to acquire better technology can increase the animal biotechnology market share.

• The rising development of vaccines due to the rapid spread of animal diseases has been adding to the demand for biotechnology. These diseases can easily spread to humans via contaminated water, food, or direct contact with an infected being. Vaccines are a great preventive measure for these diseases, which can significantly help the market growth.

• The growing population around the world increases the demand for products, leading to increased productivity in the livestock industry. This can be achieved through various methods like genome alteration with better genes, embryo transplant, etc., which will further aid the market demand for animal biotechnology.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Enhanced Productivity in Livestock Animals, Rising Education, Technologic Advancement, and the Thriving Population Likely to Provide Significant Growth Opportunities in the Animal Biotechnology Market

Enhanced Productivity in Livestock Animals

The animals can be enhanced with genome alteration and insemination to increase the production rate while improving the quality suited for humans, which is likely to lead the market growth.

Increasing Education in Animal Biotechnology

Several initiatives to increase programmes related to animal biotechnology in universities can propel the market development, and more research will help in developing better procedures which can be adopted by veterinaries.

Technological Advancement Improving Animal Biotechnology

The increasing technological developments have made it possible to carry out more complicated procedures. With the increased computing power helping to improve the processes, and implementation of the latest techniques like genomic sequencing, cloning, and direct gene insertion is expected to propel the animal biotechnology market development.

Growing Population Around the World

With the population around the world constantly growing, it simultaneously increases the demand for animal products which would, in turn, increase the adoption of livestock animals. This is a scenario especially strong in the Asia Pacific, with emerging countries like India and China having large populations, providing excellent opportunities for market expansion.

Ethical Restraints, Adverse Effects on Humans, and Strict Regulations to Pose as Challenges in the Animal Biotechnology Market

• Ethical Restraints for Animal Biotechnology -There have been several controversies about animal biotechnologies. The use of invasive procedures and genetically modified animals may have abnormalities.

• Effects on Humans by Food from Modified Animals- The adverse effects of foods produced by cloned or genetically modified animals on humans have been a frequently recurring topic.

• Regulations for Proper Procedures to Ensure Safety- There are strict guidelines to ensure safe and non-invasive methods are implemented as the cloned or modified animal may have abnormalities and result in undesirable consequences. These guidelines may hinder the speed and development of the market.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Animal Biotechnology Market Analysis

The market can be segmented based on product type into reproductive and genetic products, diagnostic tests, drugs, and vaccines. Based on the applications can be divided into food safety and drug development, and the development of animal pharmaceuticals, among others.

The regional markets can be divided into North America, Latin America, the Middle East and Africa, Europe, the Asia Pacific; among them, the Asia Pacific shows significant growth potential. The extensive EMR report, curated by expert researchers, provides detailed insights on the market based on Porter's five forces model along with giving a SWOT analysis.

The market report gives a comprehensive analysis of the following key players in the global animal biotechnology market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

• Bayer AG

• Boehringer Ingelheim International GmbH

• Zoetis Inc

• Virbac Group

• Santa Cruz Biotechnology, Inc.

• Others

Reproductive and Genetic Products, Diagnostic Tests, Drugs, and Vaccines are the Major Product Types in Animal Biotechnology Market

The growing population and demand for products have increased the adoption of animals, providing significant opportunities for the growth of the industries across all segments. The reproductive and genetic products segment has a lot of future growth possibilities as the adoption of livestock animals increases. It can include AI insemination of better breeds in lower breed cattle.

The vaccines segment is the most positively affected by the Covid 19 pandemic, leading to the increased focus on early diagnosis for abnormalities and increased vaccination adoption to develop resistance. Thus, increasing the growth of healthy animals, which will bolster the animal biotechnology market development.

The diagnostic tests segment has been multiplying, owing to the COVID 19 pandemic, to help detect and diagnose any medical condition faster and give an in-depth analysis. The drug segment develops with the diagnostic segment, as with a faster and more in-depth diagnosis of diseases, the medicines for it can be developed and administered more effectively.

Animal Biotechnology to Find Wide Applications in Food Safety and Drug Development, Development of Animal Pharmaceuticals

According to the animal biotechnology market research, the utilisation of animal biotechnology is constantly rising with the surging demand for animal products. The Food Safety and Drug Development segment has been implementing biotechnology to modify the animals so they can produce therapeutic proteins for the products, which helps the development of the segment.

For a long time, animals have been for the development of drugs for humans by testing them on animals to ensure safety and efficiency, leading to the growth of the development of the animal pharmaceuticals segment.

Asia Pacific and North America to Have a Strong Hold on the Global Animal Biotechnology Market

The Asia Pacific region is expected to show the highest growth rate in the market for animal biotechnology attributed to the high density of population and cattle adoption to meet the increasing demand. The emerging economies are also shifting toward biotechnology services such as genetic modifications and advanced diagnosis for early detection of abnormalities. This can help in the production of therapeutic products and medicines to counter diseases.

The major players and government organisations are making initiatives to develop biotechnology services, keeping animal welfare in mind. The animal biotechnology market drivers include technological advancements and innovations in countries such as China, Japan, and South Korea are increasing the animal biotechnology adoption.

North America holds the largest market share in animal biotechnology as the adoption of pet animals keeps rising, and the prevalence of diseases such as zoonosis keeps growing. The region has adopted advanced technologies for animal healthcare at an early stage. The government and private companies are taking initiatives to research and develop better procedures, which is likely to enhance the animal biotechnology market share for the region.

Competitive Landscape of Animal Biotechnology

Bayer AG: Bayer AG is a life science company innovating in the areas of healthcare and agriculture. It is one of the key market players in the animal biotechnology market. They frequently conduct animal studies with proper care and maintaining safety measures, they obtain their research animals through authorized breeders.

Bayer AG research on the latest scientific findings in animal husbandry and welfare. The research is conducted mainly on a small number of transgenic mice that are bred at Bayer.

Boehringer Ingelheim International GmbH: Boehringer Ingelheim is a leading company in the animal health industry, working with professionals on the latest innovation for the diagnosis of diseases to protect and prevent the animals from diseases. The company works for both companion animals and livestock. They have created many ground-breaking solutions by collaborating with private research companies to treat infections.

They work on human and animal diseases providing products for chronic disorders in humans, and Inhaler for asthma, stem cells to treat moderate joint inflammations in horses, and many more for multiple animals.

Zoetis Inc. is a leading key player in the animal biotechnology market. It is one of the world’s leading animal healthcare companies, driven by a goal to improve the world for animals. They provide medicines, vaccines, and diagnostic services to over 100 countries.

The primary work by the company includes detecting, diagnosing, and developing vaccines and medications for companion and livestock animals. Their products range from antiparasitic solutions to treat lice infestation to pet diabetes monitoring systems.

Key Highlights of the Report

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.